| Year |
Citation |
Score |
| 2022 |
Pennell CA, Campbell H, Storlie MD, Bolivar-Wagers S, Osborn MJ, Refaeli Y, Jensen M, Viaud S, Young TS, Blazar BR. Human CD19-specific switchable CAR T-cells are efficacious as constitutively active CAR T-cells but cause less morbidity in a mouse model of human CD19 malignancy. Journal For Immunotherapy of Cancer. 10. PMID 36521930 DOI: 10.1136/jitc-2022-005934 |
0.677 |
|
| 2018 |
Viaud S, Ma JSY, Hardy IR, Hampton EN, Benish B, Sherwood L, Nunez V, Ackerman CJ, Khialeeva E, Weglarz M, Lee SC, Woods AK, Young TS. Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory. Proceedings of the National Academy of Sciences of the United States of America. PMID 30373813 DOI: 10.1073/Pnas.1810060115 |
0.503 |
|
| 2018 |
Huang H, Viaud S, Theofilopoulos AN, Young TS, Kono DH. AI-04 Immunotherapy for lupus in a mouse model to define pathogenesis and therapeutic targeting Lupus Science & Medicine. 5. DOI: 10.1136/Lupus-2018-Lsm.4 |
0.634 |
|
| 2016 |
Besse B, Charrier M, Lapierre V, Dansin E, Lantz O, Planchard D, Le Chevalier T, Livartoski A, Barlesi F, Laplanche A, Ploix S, Vimond N, Peguillet I, Théry C, Lacroix L, ... ... Viaud S, et al. Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. Oncoimmunology. 5: e1071008. PMID 27141373 DOI: 10.1080/2162402X.2015.1071008 |
0.312 |
|
| 2014 |
Pitt JM, Charrier M, Viaud S, André F, Besse B, Chaput N, Zitvogel L. Dendritic cell-derived exosomes as immunotherapies in the fight against cancer. Journal of Immunology (Baltimore, Md. : 1950). 193: 1006-11. PMID 25049431 DOI: 10.4049/jimmunol.1400703 |
0.312 |
|
| 2014 |
Viaud S, Daillère R, Boneca IG, Lepage P, Langella P, Chamaillard M, Pittet MJ, Ghiringhelli F, Trinchieri G, Goldszmid R, Zitvogel L. Gut microbiome and anticancer immune response: really hot Sh*t! Cell Death and Differentiation. 22: 199-214. PMID 24832470 DOI: 10.1038/cdd.2014.56 |
0.402 |
|
| 2014 |
Viaud S, Daillère R, Yamazaki T, Lepage P, Boneca I, Goldszmid R, Trinchieri G, Zitvogel L. Why should we need the gut microbiota to respond to cancer therapies? Oncoimmunology. 3: e27574. PMID 24800167 DOI: 10.4161/onci.27574 |
0.493 |
|
| 2013 |
Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillère R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ, Schlitzer A, Ginhoux F, Apetoh L, Chachaty E, Woerther PL, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (New York, N.Y.). 342: 971-6. PMID 24264990 DOI: 10.1126/Science.1240537 |
0.332 |
|
| 2013 |
Hannani D, Locher C, Yamazaki T, Colin-Minard V, Vetizou M, Aymeric L, Viaud S, Sanchez D, Smyth MJ, Bruhns P, Kroemer G, Zitvogel L. Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines. Cell Death and Differentiation. 21: 50-8. PMID 23744294 DOI: 10.1038/cdd.2013.60 |
0.458 |
|
| 2011 |
Viaud S, Ploix S, Lapierre V, Théry C, Commere PH, Tramalloni D, Gorrichon K, Virault-Rocroy P, Tursz T, Lantz O, Zitvogel L, Chaput N. Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferon-γ. Journal of Immunotherapy (Hagerstown, Md. : 1997). 34: 65-75. PMID 21150714 DOI: 10.1097/CJI.0b013e3181fe535b |
0.441 |
|
| 2011 |
Viaud S, Flament C, Zoubir M, Pautier P, LeCesne A, Ribrag V, Soria JC, Marty V, Vielh P, Robert C, Chaput N, Zitvogel L. Cyclophosphamide induces differentiation of Th17 cells in cancer patients. Cancer Research. 71: 661-5. PMID 21148486 DOI: 10.1158/0008-5472.CAN-10-1259 |
0.497 |
|
| 2010 |
Viaud S, Théry C, Ploix S, Tursz T, Lapierre V, Lantz O, Zitvogel L, Chaput N. Dendritic cell-derived exosomes for cancer immunotherapy: what's next? Cancer Research. 70: 1281-5. PMID 20145139 DOI: 10.1158/0008-5472.CAN-09-3276 |
0.393 |
|
| 2009 |
Viaud S, Terme M, Flament C, Taieb J, André F, Novault S, Escudier B, Robert C, Caillat-Zucman S, Tursz T, Zitvogel L, Chaput N. Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha. Plos One. 4: e4942. PMID 19319200 DOI: 10.1371/journal.pone.0004942 |
0.457 |
|
| 2008 |
Chaput N, Conforti R, Viaud S, Spatz A, Zitvogel L. The Janus face of dendritic cells in cancer. Oncogene. 27: 5920-31. PMID 18836473 DOI: 10.1038/onc.2008.270 |
0.36 |
|
| 2008 |
Viaud S, Ullrich E, Zitvogel L, Chaput N. Exosomes for the treatment of human malignancies. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme. 40: 82-8. PMID 18283625 DOI: 10.1055/s-2007-1022548 |
0.425 |
|
| 2007 |
Ullrich E, Bonmort M, Mignot G, Chaput N, Taieb J, Ménard C, Viaud S, Tursz T, Kroemer G, Zitvogel L. Therapy-induced tumor immunosurveillance involves IFN-producing killer dendritic cells. Cancer Research. 67: 851-3. PMID 17283111 DOI: 10.1158/0008-5472.Can-06-3766 |
0.304 |
|
| Show low-probability matches. |